Abu Dhabi:The Abu Dhabi Bone Marrow Transplant Programme (AD-BMT®) team at Yas Clinic Khalifa City, in collaboration with the Abu Dhabi Stem Cells Centre (ADSCC), has successfully conducted the world's fifth reported bone marrow transplant for NIK deficiency. The procedure was performed on a 10-year-old child suffering from this rare inherited immune disorder, which is linked to a mutation in the MAP3K14 gene, after years of recurrent and life-threatening infections.
According to Emirates News Agency, MAP3K14-related NIK deficiency is a rare genetic disorder that impairs immune system development and regulation, making individuals susceptible to frequent and severe infections. The successful procedure resulted in the child, Salah Al Farawi, achieving full donor chimerism, which indicates the establishment of donor-derived blood and immune cells. Salah has fully recovered, shows no signs of active infection, and has been discharged in good health.
Salah's medical history was marked by multiple serious infections due to his compromised immune system, including cytomegalovirus affecting various parts of his body, Epstein-Barr virus in the gastrointestinal tract, and a Cryptosporidium infection that led to significant health challenges.
Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic, highlighted the achievement as a testament to the UAE's advanced clinical capabilities in managing complex inherited and immune disorders through cutting-edge diagnostics and treatments. Dr. Mansi Sachdev, Consultant in Paediatric Haematology and Bone Marrow Transplantation at Yas Clinic, emphasized the importance of finding a fully matched donor in Salah's elder brother, which was crucial to addressing the underlying immune deficiency through the transplant.
The AD-BMT® Programme offers advanced transplantation and cellular therapy services for a range of malignant and non-malignant diseases, underscoring Abu Dhabi's growing expertise in advanced healthcare.
